| Cat. No. | Size |
Price |
|
|---|---|---|---|
| RHK404-01R | 96 wells (1 kit) | $785 |
Sandwich ELISA, Biotin-labelled antibody
Serum, Urine, Plasma, Cell culture supernatant
10 µl/well
Store the complete kit at 2–8°C. Under these conditions, the kit is stable until the expiration date (see label on the box).
102-25,000 pg/ml
102 pg/ml
The total assay time is 3.5 hours
The kit measures L-FABP in human serum, plasma, urine, cell curlture supernatant
Assay format is 96 wells
Components of the kit are provided ready to use or concentrated
Energy metabolism and body weight regulation, Renal disease
Fatty acid-binding proteins (FABPs) are a class of cytoplasmic proteins that bind long chain fatty acids. FABPs are small intracellular proteins (~13-14 kDa) with a high degree of tissue specificity. They are abundantly present in various cell types and play an important role in the intracellular utilization of fatty acids, transport and metabolism. There are at least nine distinct types of FABP, each showing a specific pattern of tissue expression. Due to its small size, FABP leaks rapidly out of ischemically damaged necrotic cells leading to a rise in serum levels. Ischemically damaged tissues are characterized histologically by absence (or low presence) of FABP facilitating recognition of such areas. Liver-type fatty acid binding protein (L-FABP, FABP1) is predominantly expressed in liver. The L‑FABP protein is derived from the human FABP1 gene. L-FABP is a sensitive marker for cell damage of liver cells in vitro and in vivo. L-FABP is also a marker for rapid hepatocyte lysis in vitro (as for example in toxicology assays) and for detection of liver damage during and after transplantation. Serum/plasma and urine of healthy individuals contains approximately 12 ng/ml and 16 ng/ml.
Instructions for Use (RUO)
Instructions for Use (RUO)